Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Cash from Financing Activities (2019 - 2026)

Alx Oncology Holdings' Cash from Financing Activities history spans 5 years, with the latest figure at $59.2 million for Q4 2023.

  • On a quarterly basis, Cash from Financing Activities rose 523.19% to $59.2 million in Q4 2023 year-over-year; TTM through Dec 2023 was $59.3 million, a 501.33% increase, with the full-year FY2025 number at $362000.0, down 98.83% from a year prior.
  • Cash from Financing Activities hit $59.2 million in Q4 2023 for Alx Oncology Holdings, up from -$111000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for ALXO hit a ceiling of $188.4 million in Q4 2020 and a floor of -$769000.0 in Q2 2020.
  • Historically, Cash from Financing Activities has averaged $31.8 million across 5 years, with a median of $524000.0 in 2021.
  • Biggest five-year swings in Cash from Financing Activities: soared 3078.02% in 2020 and later tumbled 233.75% in 2023.
  • Tracing ALXO's Cash from Financing Activities over 5 years: stood at $5.9 million in 2019, then soared by 3078.02% to $188.4 million in 2020, then plummeted by 99.72% to $524000.0 in 2021, then soared by 1711.83% to $9.5 million in 2022, then surged by 523.19% to $59.2 million in 2023.
  • Business Quant data shows Cash from Financing Activities for ALXO at $59.2 million in Q4 2023, -$111000.0 in Q3 2023, and $343000.0 in Q2 2023.